Capricor

$4.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.25%) Today

+$0.09 (+2.24%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Capricor and other stocks, options, and ETFs commission-free!

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps.

CEO

Linda Marbán

Employees

Headquarters

Beverly Hills, California

Founded

2005

Market Cap

95.97M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

215.50K

High Today

$4.16

Low Today

$3.97

Open Price

$4.08

Volume

318.09K

52 Week High

$12.32

52 Week Low

$1.40

CAPR Earnings

-$0.70

-$0.47

-$0.23

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, After Hours